Conditions: Binge Eating Disorder
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 604
Healthy volunteers: no

Brief summary:
To evaluate the safety and tolerability of SPD489 administered as a daily morning dose (50 or 70mg) in the treatment of moderate to severe binge eating disorder (BED) in adults

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Lisdexamfetamine dimesylate
Intervention descriptions: intervention 1: 50 or 70 mg administered orally, once a day for 52 weeks

Protocol document: